Oculus Innovative Sciences Inc. (NASDAQ:OCLS) dropped 12% on Friday . The company traded as low as $4.10 and last traded at $4.17, with a volume of 81,281 shares changing hands. The stock had previously closed at $4.74.

Separately, Maxim Group restated a “buy” rating and issued a $3.00 price target on shares of Oculus Innovative Sciences in a research note on Friday, June 17th.

The stock’s market cap is $18.01 million. The company’s 50-day moving average price is $4.45 and its 200 day moving average price is $4.87.

Oculus Innovative Sciences (NASDAQ:OCLS) last issued its quarterly earnings data on Thursday, July 28th. The company reported ($0.61) earnings per share for the quarter. On average, equities research analysts predict that Oculus Innovative Sciences Inc. will post ($0.37) earnings per share for the current year.

Oculus Innovative Sciences, Inc is a specialty device and pharmaceutical company. The Company develops and markets solutions for the treatment of dermatological conditions and advanced tissue care in both humans and animals. The Company offers wound care products which are sold into the human and animal healthcare markets in the United States, Mexico and Europe.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.